# Pharmacokinetic Study in Healthy Adult Volunteers to Assess the Interactions Between Steady-State Tipranavir and Atazanavir in the Presence of Ritonavir

> **NCT02253836** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 21 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Tipranavir
- **DRUG:** Ritonavir
- **DRUG:** Atazanavir

## Key facts

- **NCT ID:** NCT02253836
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2005-07
- **Final completion:** —
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2014-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02253836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02253836, "Pharmacokinetic Study in Healthy Adult Volunteers to Assess the Interactions Between Steady-State Tipranavir and Atazanavir in the Presence of Ritonavir". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02253836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*